New tool aims to customize growth hormone therapy for children
NCT ID NCT06830525
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study involved 40 families of children with growth hormone deficiency. Researchers used data from connected injector devices and family surveys to develop a personalized growth hormone treatment profile (PGTP) report. The goal is to help doctors create more tailored treatment plans, similar to tools used in diabetes care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new tool that helps doctors tailor growth hormone treatment plans for each child, similar to how diabetes care is personalized.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The tool may not improve outcomes or be adopted widely in clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROWTH HORMONE DEFICIENCY (GHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Miguel Servet
Zaragoza, Aragon, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a weekly shot replace daily growth hormone for kids?
- Daily pill may replace growth hormone shots for children
- New growth hormone treatment for short children enters final testing phase
- Radiation-Free bone scan tested in kids
- Brain scan grading predicts growth problems in child tumor survivors
- Could a daily pill replace growth hormone shots for kids?